US and India discuss IP-led solutions to global pandemic

The US Chamber of Commerce’s Global Innovation Policy Center (GIPC) and US-India Business Council, in partnership with the Federation of Indian Chambers of Commerce and Industry (FICCI), convened government and industry leaders for the final session of its 4th annual IP Dialogue.

“IP Dialogue: Opportunities for US-India Collaboration” featured experts from India’s Department for Promotion of Industry and Internal Trade (DPIIT), US Patent and Trademark Office, US International Trade Administration, US Department of State, and Office of the US Trade Representative, along with other government, private sector and academic experts. Participants discussed a broad range of IP-related topics, including how to support IP commercialisation, challenges in fighting the global pandemic, barriers to domestic innovation, and the “next generation” of IP policy discussions in the digital economy.

“Thanks to years-long research and development led by the private sector, our world has many safe and effective vaccines and treatments to combat COVID-19. And, nearly two years since the global pandemic began, we continue to make steady progress. However, challenges remain to getting shots in arms—such as scarce raw materials, regulatory delays and other barriers. India has long been a hub for research, development and manufacturing of biopharmaceutical products—complementing similar work underway in the US. The IP Dialogue is a means by which these two countries can not only discuss shared goals, but ways to get there,” said Patrick Kilbride, Senior Vice President, Global Innovation Policy Center, US Chamber.

Adding to it, Nisha Biswal, President, US-India Business Council, US Chamber, said, “……..The US Chamber is excited about India’s plan to create a $1 trillion digital economy—and to assist in the exchange of the best practices and knowledge, we host the US-India IP Dialogue. The IP Dialogue is an opportunity for the US and Indian governments to come together to discuss an issue critical to our bilateral relationship—particularly since the two sides are set to meet next week for the Trade Policy Forum.”